Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: IA NONMETROPOLITAN AREA — October 2026
Nonmetro Iowa's thin talent pool reshapes build-vs-outsource math.
Validation Engineer pay jumped to $121,331 against a national $106,478, while Clinical Data Manager pay collapsed to $74,125 versus $123,653 nationally, underscoring how uneven nonmetro Iowa's specialist market has become.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Iowa unemployment rate: 3.2% — Fifth straight month; vs 4.2% nationally
- Labor force participation: 66.9% — Falling on retirements, education exits
- Nonmetro wage disadvantage: 94 of 95 counties — Below national avg weekly wage, Q1 2026
- National life sciences quit rate: 1.9% — Constrains specialist candidate movement
Key takeaways
Validation Engineer pay jumped sharply while Research Scientist pay stalled.
Validation Engineer advertised pay rose significantly to $121,331, outpacing the national median of $106,478, while Research Scientist pay held flat at $109,495 against a national figure climbing to $130,339. Manufacturing and quality-adjacent credentials appear to command a premium locally that core R&D roles currently do not.
Clinical Data Manager pay collapse signals a thinning local specialist bench.
Metro median pay for Clinical Data Manager fell significantly to $74,125, well below the stable national figure of $123,653. A gap this wide may reflect fewer advertised postings at senior pay bands, which is worth testing before using this figure to anchor offers.
Regulatory Affairs pay strength breaks from the national pattern.
Local Regulatory Affairs Specialist pay rose significantly to $103,011, even as the national median slipped moderately to $103,780. Convergence with national levels suggests nonmetro employers are bidding up compliance talent to close a credential gap, holding ground against coastal markets.
Clinical Research Associate pay divergence complicates CRO benchmarking.
Metro CRA pay fell moderately to $123,682 while national CRA pay rose significantly to $90,065 — a reversal that leaves local advertised rates well above the national figure. Decisions to insource versus outsource clinical operations should account for this unusual premium and treat it as distinct from national CRO rate cards.
Median advertised pay by role — IA NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist | $104,805 | $109,495 | $119,207 | Stable | $130,339 |
| Clinical Research Associate | $98,681 | $123,682 | $133,101 | Moderate decline | $90,065 |
| Lab Technician | $40,091 | $47,884 | $53,005 | Moderate increase | $47,840 |
| Regulatory Affairs Specialist * | $88,842 | $103,011 | $109,084 | Significant increase | $103,780 |
| Clinical Data Manager * | $74,125 | $74,125 | $99,228 | Significant decline | $123,653 |
| Biostatistician * | $91,938 | $124,129 | $146,223 | Stable | $131,958 |
| Validation Engineer * | $118,498 | $121,331 | $123,498 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Rural Iowa's labor pool continues to tighten as labor force participation slides to 66.9% on retirements and workers exiting for education, even as statewide unemployment holds at a historically low 3.2% for a fifth straight month. Nonmetro counties remain structurally disadvantaged for life sciences recruiting — 94 of 95 smaller counties post average weekly wages below the national average, making it harder to compete for credentialed scientific and regulatory talent against metro and coastal employers.
What it means
Thin, aging local labor supply combined with a national quit rate of 1.9% means nonmetro Iowa life sciences employers face a double constraint: specialists are staying put in their current roles, and the local pipeline replacing retirees is shallow. With lab/R&D vacancy at 23.2% nationally and CRA talent scarce, build-vs-outsource tradeoffs with CDMOs and CROs deserve fresh scrutiny wherever nonmetro facilities carry vacant regulatory, quality or bioprocess roles. Consider reviewing which open scientific and regulatory positions have sat vacant longest, and testing whether CDMO partnership costs now compare favorably to sustained in-house recruiting delays.
Looking ahead
Early indicator: Watch whether Q2 2026 QCEW county-level data, released October 30 by Iowa Workforce Development, reveals which nonmetro counties are gaining or losing life sciences-adjacent employment. This is the first granular read available since the state-level unemployment plateau began.
Emerging pressure point: Labor force participation decline tied to retirements threatens succession pipelines in quality and manufacturing roles, where nearly a quarter of the national life sciences workforce is 55 or older. Nonmetro facilities with concentrated tenure risk should flag succession gaps before Q1 planning cycles.
Worth watching: Professional, scientific and technical services employment losses statewide in September could either signal softening demand or a shift of talent toward CRO/CDMO employers. Track whether released talent shows up in nonmetro applicant pools over the next two months.
Potential inflection point: Manufacturing WARN activity remains elevated statewide (54 notices, 4,255 workers year-to-date) even as overall layoffs fall. A nonmetro manufacturing notice affecting bioprocess or device production would be a meaningful signal for local build-vs-outsource calculus.
Sources
- Iowa Workforce Development — Iowa labor force participation fell to 66.9% in September
- Iowa Workforce Development / BLS QCEW — 94 of 95 smaller Iowa counties below national average weekly wage
- Bureau of Labor Statistics / industry survey — National quit rate sits at 1.9% in biopharma/biotech
- Industry life sciences labor market survey — Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets
- Iowa Workforce Development — Iowa unemployment rate held at 3.2% for fifth consecutive month
- LayoffIQ — Iowa manufacturing WARN filings: 54 notices affecting 4,255 employees YTD
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.